Product Information

PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.3997 per EA under NDC 62175047232. Its NADAC has been published 519 times since Sep 14, 2016.

FDA first approved this application on Jun 10, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PAROXETINE ER 37.5 MG TABLET

Paroxetine Hydrochloride
$0.3997per EA

Strength

37.5 mg/1

NDC

62175047232

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PAROXETINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204744

FDA Approved

6/10/2016

TE Code

AB

On Market Since

10/31/2014

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 519 times since Sep 14, 2016, and over the history we have for it it has declined 91.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3997 per EA
All-time high$4.6624 (Nov 16, 2016)
All-time low$0.3671 (Nov 20, 2024)
52-week high$0.5530
52-week low$0.3997
Median price$1.1608
Average price$1.6594
Largest weekly change+50.9% (Feb 22, 2023)
Weeks tracked519
Tracking sinceSep 14, 2016

Price History

1W

-2.3%

1M

-2.3%

3M

-1.2%

6M

-17.4%

1Y

-18.4%

3Y

-47.8%

5Y

-66.3%

All

-91.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Paroxetine Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Lannett Company Inc., is $0.3997 per EA (NDC 62175047232), effective Aug 19, 2026.

How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 91.1%. It has been tracked across 519 weekly CMS publications since Sep 14, 2016.

What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?

Since Sep 14, 2016, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $4.6624 (Nov 16, 2016), with a median of $1.1608 per EA.

Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PAROXETINE ER 37.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PAROXETINE ER 37.5 MG TABLET?

PAROXETINE ER 37.5 MG TABLET (NDC 62175047232) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.